Literature DB >> 6490636

Peptidoglycans as promoters of slow-wave sleep. I. Structure of the sleep-promoting factor isolated from human urine.

S A Martin, M L Karnovsky, J M Krueger, J R Pappenheimer, K Biemann.   

Abstract

Fast atom bombardment-mass spectrometry (FABMS) has been used to determine the structure of the urinary sleep-promoting factor (FSu), the nature of whose components had been reported earlier. Less than 1 nmol of the underivatized substance sufficed for the FABMS experiments. The major somnogenic constituent of the purified preparation was a peptidoglycan of Mr = 921 with the structure N-acetylglucosaminyl-N -acetylanhydromuramylalanylglutamyldiaminopimelylalanine. The anhydro linkage is between C-1 and C-6 of the muramyl entity. Two additional substances accompanied the above compound. These were the hydrated form (i.e. in which the muramyl entity had a free reducing end, and a free hydroxyl on C-6), and an anhydro analogue lacking the terminal alanine. The Mr values were 939 and 850, respectively. Methyl esters were prepared, and these were also acetylated. The mass spectra of the methyl ester of Mr = 921 displayed an increase in Mr of 42 (i.e. 3 X 14), indicating the presence, originally, of three free carboxyls. Acetylation increased Mr by a further 168 units (i.e. 4 X 42), indicating 4 hydroxyl or amino groups. These data are consistent with the structure cited above for the main entity of FSu. Similar confirmatory results were obtained for the two minor constituents described above. These operations were worked out on natural muramyl peptides of known structure, obtained from other sources, and the data are given for comparison.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6490636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Endogenous synthesis of peptidoglycan in eukaryotic cells; a novel concept involving its essential role in cell division, tumor formation and the biological clock.

Authors:  C A Roten; D Karamata
Journal:  Experientia       Date:  1992-10-15

Review 2.  Role of biological membranes in slow-wave sleep.

Authors:  M L Karnovsky
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

3.  Gut microbes extend reach to systemic innate immunity.

Authors:  Dana J Philpott; Stephen E Girardin
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

4.  Toll-like receptor 2-mediated peptidoglycan uptake by immature intestinal epithelial cells from apical side and exosome-associated transcellular transcytosis.

Authors:  Heng-Fu Bu; Xiao Wang; Yi Tang; Viola Koti; Xiao-Di Tan
Journal:  J Cell Physiol       Date:  2010-03       Impact factor: 6.384

5.  Trace levels of peptidoglycan in serum underlie the NOD-dependent cytokine response to endoplasmic reticulum stress.

Authors:  Raphael Molinaro; Tapas Mukherjee; Robert Flick; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2019-04-17       Impact factor: 5.157

6.  Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis.

Authors:  E Simelyte; M Rimpiläinen; X Zhang; P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

7.  Peptidoglycan fragments decrease food intake and body weight gain in rats.

Authors:  K J Biberstine; R S Rosenthal
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase.

Authors:  H Engel; A J Smink; L van Wijngaarden; W Keck
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

10.  Murein-metabolizing enzymes from Escherichia coli: sequence analysis and controlled overexpression of the slt gene, which encodes the soluble lytic transglycosylase.

Authors:  H Engel; B Kazemier; W Keck
Journal:  J Bacteriol       Date:  1991-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.